Empery Asset Management, LP 13D/13G Filings for BriaCell Therapeutics Corp. (BCTX)

Empery Asset Management, LP 13D and 13G filings for BriaCell Therapeutics Corp.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-01-20
09:47 am
Sale
2021-12-3113GBriaCell Therapeutics Corp.
BCTX
Empery Asset Management, LP33,333
2.520%
-760decrease
(-2.23%)
Filing
2021-03-02
12:06 pm
Purchase
2021-02-2313GBriaCell Therapeutics Corp.
BCTX
Empery Asset Management, LP34,094
8.890%
34,094increase
(New Position)
Filing